Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Director departure
|
Iterum Therapeutics plc (ITRM)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/11/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
05/12/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
11/10/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
08/12/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
05/13/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
11/12/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
08/13/2021 |
10-Q
| Quarterly Report for the period ended June 30, 2021 |
05/14/2021 |
10-Q
| Quarterly Report for the period ended March 31, 2021 |
11/16/2020 |
10-Q
| Quarterly Report for the period ended September 30, 2020 |
08/06/2020 |
10-Q/A
| Quarterly Report for the period ended March 31, 2020 [amend] |
08/06/2020 |
10-Q
| Quarterly Report for the period ended June 30, 2020 |
05/14/2020 |
10-Q
| Quarterly Report for the period ended March 31, 2020 |
11/12/2019 |
10-Q
| Quarterly Report for the period ended September 30, 2019 |
08/14/2019 |
10-Q
| Quarterly Report for the period ended June 30, 2019 |
05/14/2019 |
10-Q
| Quarterly Report for the period ended March 31, 2019 |
11/14/2018 |
10-Q
| Quarterly Report for the period ended September 30, 2018 |
08/14/2018 |
10-Q
| Quarterly Report for the period ended June 30, 2018 |
|
|